BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9407421)

  • 1. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
    Hansen HP; Nielsen FS; Rossing P; Jacobsen P; Jensen BR; Parving HH
    Kidney Int Suppl; 1997 Dec; 63():S49-53. PubMed ID: 9407421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
    Rossing P; Hommel E; Smidt UM; Parving HH
    Kidney Int Suppl; 1994 Feb; 45():S145-9. PubMed ID: 8158884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
    Hansen HP; Rossing P; Tarnow L; Nielsen FS; Jensen BR; Parving HH
    Kidney Int; 1995 Jun; 47(6):1726-31. PubMed ID: 7643542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
    Schjoedt KJ; Lajer M; Andersen S; Tarnow L; Rossing P; Parving HH
    Scand J Clin Lab Invest; 2006; 66(3):173-80. PubMed ID: 16714246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy.
    Hansen HP; Christensen PK; Tauber-Lassen E; Klausen A; Jensen BR; Parving HH
    Kidney Int; 1999 Feb; 55(2):621-8. PubMed ID: 9987086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.
    Jerums G; Panagiotopoulos S; Premaratne E; Power DA; MacIsaac RJ
    Am J Nephrol; 2008; 28(4):614-27. PubMed ID: 18285683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular dysfunction in diabetic nephropathy.
    Zucchelli P; Zuccalà A; Sturani A
    Postgrad Med J; 1988; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive treatment inhibiting the progression of diabetic nephropathy.
    Mogensen CE
    Acta Endocrinol Suppl (Copenh); 1980; 238():103-8. PubMed ID: 6933807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal autoregulation is normal in newly diagnosed, normotensive, NIDDM patients.
    New JP; Marshall SM; Bilous RW
    Diabetologia; 1998 Feb; 41(2):206-11. PubMed ID: 9498655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH; Hommel E; Jensen BR; Hansen HP
    Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Smidt UM; Chen JW; Sato A; Parving HH
    Scand J Clin Lab Invest; 1997 Aug; 57(5):427-34. PubMed ID: 9279969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
    Ruggenenti P; Perna A; Mosconi L; Matalone M; Pisoni R; Gaspari F; Remuzzi G
    Kidney Int Suppl; 1997 Dec; 63():S54-7. PubMed ID: 9407422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age as a determinant of glomerular filtration rate in non-insulin-dependent diabetes mellitus.
    Rius F; Pizaro E; Salinas I; Lucas A; Sanmarti A; Romero R
    Nephrol Dial Transplant; 1995; 10(9):1644-7. PubMed ID: 8559483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
    Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of antihypertensive treatment on kidney function in insulin-dependent (type I) diabetics with renal failure.
    Zander E; Conde N; Heinke P; Zander G; Strese J; Gums G; Schulz B
    Exp Clin Endocrinol; 1990 Feb; 95(1):70-6. PubMed ID: 2335182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial.
    Schjoedt KJ; Christensen PK; Jorsal A; Boomsma F; Rossing P; Parving HH
    Nephrol Dial Transplant; 2009 Nov; 24(11):3343-9. PubMed ID: 19561152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.